Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Cancer Research and Treatment|January 26, 2023
Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid LeukemiaSeo-Yeon Ahn, TaeHyung Kim, Mihee Kim, et al.Journal of Korean Medical Science|October 24, 2023
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From KoreaJin Seok Kim, Jun Ho Jang, Deog-Yeon Jo, et al.Bone Marrow Transplantation|December 6, 2020
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencingJae-Sook Ahn, TaeHyung Kim, Sung-Hoon Jung, et al.Blood Research|February 25, 2021
Updated recommendations for the treatment of venous thromboembolismJunshik Hong, Seo-Yeon Ahn, Yoo Jin Lee, et al.Blood|August 16, 2018
Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapseTaeHyung Kim, Joon Ho Moon, Jae-Sook Ahn, et al.Bone Marrow Transplantation|September 23, 2022
Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemiaGa-Young Song, TaeHyung Kim, Seo-Yeon Ahn, et al.Scientific Reports|November 19, 2020
RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemiaTaeHyung Kim, Joon Ho Moon, Jae-Sook Ahn, et al.Oncotarget|January 1, 2017
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemiaJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.Oncotarget|February 14, 2018
Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotypeJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.Scientific Reports|April 12, 2024
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemiaGa-Young Song, Hyeon-Jong Kim, TaeHyung Kim, et al.Pageof 7